Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 916

Similar articles for PubMed (Select 9004051)

1.
2.

Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.

De Bellis MD, Geracioti TD Jr, Altemus M, Kling MA.

Biol Psychiatry. 1993 Apr 15-May 1;33(8-9):636-41.

PMID:
7687151
3.

The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients.

Lundmark J, Wålinder J, Alling C, Manniche PM, Dalgaard L.

Eur Neuropsychopharmacol. 1994 Mar;4(1):1-6.

PMID:
7515737
4.

Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.

Mårtensson B, Nyberg S, Toresson G, Brodin E, Bertilsson L.

Acta Psychiatr Scand. 1989 Jun;79(6):586-96.

PMID:
2475012
5.

A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.

Timmerman L, de Beurs P, Tan BK, Leijnse-Ybema H, Sanchez C, Høpfner Petersen HE, Cohen Stuart MH.

Int Clin Psychopharmacol. 1987 Jul;2(3):239-53.

PMID:
2447151
6.

Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.

Mendlewicz J, Pinder RM, Stulemeijer SM, Van Dorth R.

J Affect Disord. 1982 Sep;4(3):219-26.

PMID:
6182175
7.

Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.

Potter WZ, Scheinin M, Golden RN, Rudorfer MV, Cowdry RW, Calil HM, Ross RJ, Linnoila M.

Arch Gen Psychiatry. 1985 Dec;42(12):1171-7.

PMID:
2416297
8.

Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.

Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé AA.

J Clin Psychopharmacol. 2010 Oct;30(5):496-503. doi: 10.1097/JCP.0b013e3181f2288e.

PMID:
20814316
9.

Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.

Bowden CL, Koslow SH, Hanin I, Maas JW, Davis JM, Robins E.

Clin Pharmacol Ther. 1985 Mar;37(3):316-24.

PMID:
2578912
10.

A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.

Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Oquendo MA.

Bipolar Disord. 2006 Oct;8(5 Pt 2):543-50.

PMID:
17042827
12.

Effect of propranolol on monoamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia.

Scheinin M, van Kammen DP, Ninan PT, Linnoila M.

Clin Pharmacol Ther. 1984 Jul;36(1):33-9.

PMID:
6203678
13.

[Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].

Raucoules D, Levy C, Azorin JM, Bruno M, Valli M.

Encephale. 1992 Nov-Dec;18(6):611-6. French.

PMID:
1285270
15.

Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression.

Little JT, Ketter TA, Mathé AA, Frye MA, Luckenbaugh D, Post RM.

Biol Psychiatry. 1999 Feb 1;45(3):285-9.

PMID:
10023503
17.

Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment.

Bäckman J, Alling C, Alsén M, Regnéll G, Träskman-Bendz L.

Eur Neuropsychopharmacol. 2000 Sep;10(5):341-9.

PMID:
10974605
18.

Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.

Ashby P, Verrier M, Warsh JJ, Price KS.

J Neurol Neurosurg Psychiatry. 1976 Dec;39(12):1191-200.

19.

Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.

Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH.

Biol Psychiatry. 2004 Sep 15;56(6):418-26.

PMID:
15364040
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk